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Introduction
Atrial fibrillation is one of the most
common heart arrhythmias
(Schumacher et al., 2018). From
diagnosis to treatment, some risk
. factors that are common causes of
heart arrhythmias is atrial fibrillation.
So many patients are not
knowledgeable about some of the risk
factors and causes of atrial
fibrillation. The practitioner can
further assist patients by educating
patient’s on actions of fatty acids,
calcium contributions, PR interval
prolongation, and how sinus node
dysfunction can contribute to atrial
fibrillation (Schumacher, et al., 2018).

Presentation of Case
A 45-year-old male with no prior history of
cardiovascular disease comes to the
emergency department with complaints of
shortness of breath and bilateral lower
extremity edema for one month. He stated
what brought him in today was his chest pain
that did not go away after he rested today.
He is afebrile with a heart rate of 160,
respirations 16, blood pressure 120/88, and
pulse ox 100%. His lungs have some faint
crackles at the bases. There is noted pitting
edema +2 bilateral extremities in ankles and
feet. His EKG reveals atrial fibrillation. The
physician orders an IV line and to start a
Cardizem drip titrating until his heart rate is
under 100. Also, a bolus of 10mg of Cardizem
administered. Cardizem is an antiarrhythmic
drug to help control the heart rate and keep
the rhythm under control by keeping the
heart rate under 100 beats per minute
(Jackson, 2017). The patient is admitting to
the cardiac floor, where the cardiologist will
further evaluate him. Echocardiogram and
series of troponin labs ordered. The patient is
at risk for blood clots the physician orders
Lovenox based per patients’ weight will be
administered. The cardiologist considers
cardioversion to shock the rhythm back into a
sinus rhythm. Cardiologist decides to wait
one month on blood thinners to do
cardioversion to ensure that a stroke will not
happen. Other surgical treatments with
chronic atrial fibrillation that may be
considered in the future. Permanent
pacemaker may be considered to administer
antiarrhythmic or ventricle rate controlling
medication. Another surgical possibility is left
atrial ablation to fix the mix firing of the
electrical system (Zaman, 2017) (Zaman,
2017) (Zaman, 2017). This surgery works by
scarring the tissue to disrupt the
malfunctioning electrical signals causing the
arrhythmia (Jackson, 2017).

Pathophysiological Process
Pathophysiology
Underlying
Pathophysiology
Atrial Fibrillation occurs when the atria
become so irritable that it no longer is
beating, but mostly quivering
ineffectively. Electrical impulses typically
start in the sinoatrial node, and a cardiac
action potential travels throughout the
atrial muscle and down to atrioventricular
node. Action potential slows considerably
at the atrioventricular node because of the
fiber's smaller diameter. This delay gives
the atria time to complete the contraction
and adds the volume of blood in ventricles
before ventricle contraction begins. Action
potential enters the atrioventricular
bundle, and conduction is rapid again. The
entire ventricular myocardium undergoes
depolarization after the action potential
rises in the sinoatrial nodes. In atrial
fibrillation, the atrioventricular node must
be blocked by some of the impulses to
keep ventricle rate reasonable. The
cardiac rhythm of atrial fibrillation is
grossly irregular. The atria's waves are
conducting chaotically (Zaman, 2017).

Depolarization facilities a small
amount of calcium in each cell from
the calcium channel at the beginning
of each contraction. Calcium enters
atrial cells with each action
potential. When atrial rates are
rapid and chaotic, this increases the
calcium loading. Homeostasis is
initiated by protective mechanisms
that reduce calcium entry and
decrease calcium production and
collapsing potassium current
(Denham et al., 2018). Calcium
remodels atrial stimulation by
signaling calcium to remain silent in
the channels. Calcium remodeling is
a protective reaction that can
eventually develop atrial fibrillation.
This action shows the strong
influence of calcium remodeling
abilities to initiate atrial fibrillation
(Denham et al., 2018). Calcium and
other electrolytes can affect the
conduction by prolonging the PR
interval. Prolonging of the PR
interval happens with the result of
delays in impulse conduction. When
PR interval prolongation happens, it
can lead to a miss firing of the
electoral system can cause atrial
fibrillation or other heart conditions
(Schumacher et al., 2018 ).

References
Significance of Underlying
Pathophyslology
The exact mechanisms by which cardiovascular risks predispose patients to
atrial fibrillation are unknown. Some common risks factors associate with atrial
fibrillation is neurotransmitter excess, hemodynamic stress, atrial ischemia,
atrial inflammation, metabolic stress, and neurohumoral cascade activation is
thought to cause this arrhythmia. The risks are conclusive that the grouping of
fatty acids plays a part in risk factors of atrial fibrillation. Fatty acids patterns in
adipose tissue share dietary sources and metabolic pathways. These increase
the chances of atrial fibrillation to develop (Dinesen et al., 2018). Generally,
with atrial fibrillation will develop congestive heart failure (Carlisle, 2019).

Implication for Nursing Care
•Education and reinforcement of knowledge
•Knowing risk factors of atrial fibrillation. – modifiable risk factors *smoking
cessation, exercises, weight management.
•Helping patient implement these and the importance of follow up with physician.
•Preventing thromboembolism and controlling heart rate
•Stressing follow up with physician and medication management.
•Signs and symptoms of acute flare ups and stroke symptoms.
•Being physically fit can help defer atrial fibrillation. It can stabilize
the atrial fibrillation in paroxysmal type of atrial fibrillation
(Turagam, Flaker, Velagapudi, Vadali, & Alpert, 2015).

https://rebelem.com/afib-wait-and-see-or-early-cardioversion-to-obtain-normalsinus-rhythm/

Signs and Symptoms
Most common symptom is quivering or
fluttering heartbeat
Rapid or irregular heartbeat (rapid,
fluttering, or pounding)
General fatigue
Dizziness
Shortness of breath
Weakness
Faintness or confusion
Fatigue when exercising
Sweating
Chest pain or pressure
(CDC, 2017)
https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_atrial_fibrillation.htm

AF-rapid-ventricular-response.jpg file
Different types of Atrial fibrillation
Paroxysmal- less than seven days (over time
may become more often and last longer
leading to chronic).
Persistent- lasts longer than seven days
Permanent- does not go away no matter the
treatment
Long standing- heart rate is irregular and lasts
longer than twelve months
Nonvalvular- not caused by the heart valve
issue.
All types can increase risk for stroke.
(Association, 2019)

Conclusions
Atrial fibrillation can have a range of symptoms and
treatment. Best results of atrial fibrillation are
knowledge of what to look for to minimize
symptoms. Atrial fibrillation is not fatal but needs
treatment when uncontrolled. Best treatment is to get
patient back into a sinus rhythm by medications,
cardioversion and/or surgical intervention if chronic
atrial fibrillation.
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